Post-Acne Dark Spots and Melasma: Treatment and Differences

You may notice a dark mark left by a spot and broader brown patches on your cheeks that become more noticeable in summer. Advertisements often call all of this “pigmentation” and suggest the same laser. But post-inflammatory hyperpigmentation (PIH), melasma and individual sun spots are different conditions. The distinction affects treatment and the risk of making marks darker. Assessing the skin, protecting it from light and trying gentle topical care are often better starting points; devices are not right for every situation.

Acne marks or melasma: how can you tell them apart?

PIH is excess pigmentation after skin inflammation or injury. It can follow acne, eczema, bites, burns or overly harsh skincare. Inflammation may have resolved while a brown, grey-brown or bluish mark persists. Pigment deeper in the skin may take longer to fade. PIH can affect any skin tone, but often presents a greater burden in darker phototypes.

Melasma more often appears as broad, sometimes symmetrical patches on the cheeks, forehead, upper lip or bridge of the nose. Light exposure and individual predisposition matter; pregnancy and hormonal influences sometimes contribute. It can return after successful fading, which does not mean you have cared for your skin badly. Melasma, acne marks and solar lentigines (distinct sun-related spots) can occur together.

Colour and location offer clues, not a diagnosis. Grey tones can suggest deeper pigment, but photographs cannot reliably establish its depth or exclude another disease. Irritating creams may cause further marks and hormonal changes may sustain melasma. Two people offered the same “brightening” routine may therefore respond very differently.

When does a “cosmetic spot” need a medical check first?

An in-person dermatology assessment comes first if a mark is new and growing, looks unlike your other spots, changes colour or shape, bleeds or develops a sore that will not heal. Asymmetry, irregular edges and mixed colours are warning signs, although their absence does not prove safety. Suspicious pigmented lesions need assessment, sometimes dermoscopy or a biopsy chosen by the clinician, not a trial of acids or laser.

Seek assessment too for unusually widespread pigmentation, marked itching, inflammation, changes of the mucous membranes or other symptoms unlike ordinary acne marks. The dermatologist considers timing, medications, sun sensitivity, pregnancy and examination findings. Blood tests are not automatic for everyone with melasma; they depend on clinical indications. A do-it-yourself lamp test cannot replace examination.

What is genuinely useful at home before procedures?

The foundation is sun protection you can comfortably use every day. Dermatology guidance for melasma recommends broad-spectrum sunscreen of at least SPF 30, shade, a hat and reapplication according to exposure. A tinted sunscreen containing iron oxides can also help protect against some visible light, which matters in melasma and PIH. The concern here is mainly sunlight; there is no reason to treat phone screens as the primary cause.

Consistency matters more than a costly bottle. Cover the face and exposed skin, including ears and neck, and reapply after sweating, swimming and extended outdoor exposure according to the product directions. If a tint is unpleasant, find one you will actually wear. For easily irritated skin, choose a gentle fragrance-free formula. Burning from “active” products does not mean they are removing pigment faster; irritation can worsen PIH.

The next priority is to stop making new spots. Treat active acne as well as the marks it leaves. If peels or brushes keep inflaming your skin, simplify your routine temporarily to mild cleansing, moisturiser and sun protection. Avoid picking lesions to minimise injury. Camouflage makeup is a reasonable choice for work or photographs as long as it does not irritate you; it does not undermine treatment.

Which treatments fit different kinds of pigmentation?

PIH may be treated with topical ingredients that influence pigment production or cell turnover, such as azelaic acid, selected retinoids and clinician-prescribed hydroquinone, sometimes alongside other agents. Response depends on depth, control of inflammation and tolerability. Starting several irritating products at once makes it difficult to identify the cause if redness and peeling develop.

For melasma, a dermatologist may prescribe hydroquinone or a triple-combination prescription cream containing hydroquinone, a retinoid and a corticosteroid. These regimens need appropriate indications, a limited and reviewed duration, and monitoring for adverse effects. They are not ordinary creams for indefinite self-treatment: irritation and unwanted pigment changes can occur. Azelaic acid or another gentler option may suit someone with sensitive skin or a contraindication.

Tranexamic acid is sometimes considered for difficult melasma, including oral use in selected patients. Tablets are not a beauty supplement. The prescriber must assess thrombosis history, other clotting risks, combined hormonal contraception and other contraindications. For example, current US tablet labelling explicitly lists combined hormonal contraception and thrombotic conditions as contraindications. Oral use for melasma may be off-label locally; a US label does not set Armenian prescribing rules. Do not self-prescribe it. If vision changes suddenly while taking the tablets, stop taking them and seek urgent medical advice; chest pain, unexplained breathlessness or painful swelling of one leg also need emergency assessment. During pregnancy avoid retinoids and hydroquinone; when planning pregnancy or breastfeeding, review each treatment individually with a clinician rather than assuming the pregnancy advice automatically covers lactation.

Chemical peels, IPL and lasers may sometimes be added after basic treatment. With melasma, excessive heat or injury can provoke worsening or recurrence; in PIH the procedure itself can create new inflammation. Laser treatment for melasma is therefore a separate decision, not the automatic next step after a cream. Before considering laser treatment of pigmented spots, establish both the diagnosis and the exact technology.

When might changes appear, and what will others see?

Topical treatment works gradually, so review progress over weeks and months rather than the next morning. The American Academy of Dermatology says results from a prescribed melasma plan often take 3–12 months, sometimes longer. Superficial PIH can also fade over months and deeper pigmentation may persist substantially longer. These are discussion guides, not personalised deadlines.

Regular sunscreen has no social downtime; some active products can cause dryness, stinging or temporary redness. A peel may visibly flake, while lasers can cause more pronounced redness, crusting and specialised aftercare. If a wedding, work trip or major photo session is approaching, avoid booking your first intensive treatment right before it. Healing and tolerance vary. Ask when it will be safe to resume makeup, exercise, sun exposure and your usual skincare.

A “natural” result here usually means reduced contrast between spots and surrounding skin, not a perfectly identical tone in every photograph. Compare before-and-after images taken in matching light and with the same makeup conditions, ideally without filters. Look at follow-up duration and recurrence as well as the most flattering image. A picture immediately after treatment cannot prove lasting results.

Why can pigmentation return, and what comes after improvement?

Melasma often behaves as a long-term condition: after intensive treatment ends, sunlight, visible light and personal triggers remain. Maintenance matters and may be simpler than the original course, typically involving consistent sun protection and agreed topical care. Do not extend strong prescription combinations indefinitely without review. For PIH, preventing new inflammation usually matters more than endlessly treating old dots.

If spots are not fading, review the diagnosis, product quantities, regularity of protection, hidden irritation and active acne—not just the strength of the cream. Sometimes the issue is the wrong diagnosis rather than a need for a more powerful device. Unexpected darkening after a procedure also warrants reassessment: do not try to fix it yourself with another peel.

How can you discuss a plan without pressure?

Questions for a consultation include: What is the diagnosis for each group of spots? Does anything need dermoscopy? Are we treating inflammation or pigment first? What could realistically improve over months, and what cannot? What is my risk of PIH given my skin tone? Which medications and acids should be paused, what should I do if irritated, and how will we compare progress in similar lighting?

If a device-based treatment is suggested, ask for the exact technology, clinician qualifications, expected visible downtime, potential complications and how they would be handled. Request a breakdown of the course and aftercare costs; area, diagnosis, visits and prescriptions affect the total. Claims that “every spot disappears in one session” justify a second opinion. Delaying a procedure while establishing good sun protection is a valid choice.